Enhancing the added value of pharmaceutical glass products is the key to industry upgrading

Introduction: Pharmaceutical glass packaging is a component of traditional Chinese medicine packaging, and is used for packaging water injections, infusion bottles, and other products. The pharmaceutical industry hs become a permanent industry that people rely on for survival, and human health cannot be separated from medicine. With the progress of society and the improvement of people's living standards, the proportion of new drugs, specialty drugs, and high-end and valuable drugs will gradually increase. These types of drugs will put forward higher demands for the updating and upgrading of medicinal glass.

At present, there is a significant gap in the manufacturing quality level of domestic infusion bottles compared to similar international products, mainly in terms of bottle lightweighting, cleanliness, packaging and appearance transparency, uniformity, etc. Therefore, enhancing the added value of pharmaceutical glass packaging products has become a necessary path for the industry, but there are many bottlenecks in upgrading and upgrading.

For injections, substandard visible foreign objects have become a very challenging issue affecting product quality. The main reason for the non conformity of "visible foreign objects" is the influence of packaging containers and glass bottles. The reason for this problem is, on the one hand, that many glass pipe and ampoule production enterprises do not meet the purification requirements in their working environment; On the other hand, the characteristics of the 7.0 low borosilicate glass commonly used in domestic injections have a significant impact on drugs, especially on alkaline drugs that are prone to problems such as detachment and white spots, and its water resistance and alkaline ion precipitation.

The upgrade of pharmaceutical glass packaging means that the market for high-end pharmaceutical packaging materials such as neutral glass will usher in spring. However, it is understood that due to the lack of large-scale production of neutral borosilicate first grade water-resistant glass in China, the pipes used are basically imported, with an annual import volume of about 3000 tons. The proportion of 5.0 glass bottles produced in domestic injection is relatively small. With the development of China's pharmaceutical industry, this demand is constantly increasing, and the annual growth rate of imported pipes and glass bottles has reached over 20%. However, the production of glass has its own particularity. Once the furnace is opened, it cannot be stopped, otherwise the furnace will be scrapped, and to resume production, a new furnace will have to be built, which comes at a very high cost However, the problems encountered by pharmaceutical companies in the upgrading and replacement of glass packaging have hindered the development of the pharmaceutical glass market.

To successfully upgrade and transform pharmaceutical glass packaging, it is necessary to gradually promote the upgrading and replacement of pharmaceutical packaging materials through market means. At the same time, pharmaceutical companies and packaging material production companies should work together to promote the better application of pharmaceutical glass packaging in the pharmaceutical industry.